Type 2 Biomarkers and Bronchiectasis.

IF 3.9 2区医学 Q1 RESPIRATORY SYSTEM Lung Pub Date : 2024-08-01 DOI:10.1007/s00408-024-00716-z

Robert M Rutherford, Micheal J Harrison

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

2 型生物标志物与支气管扩张症。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Lung 医学-呼吸系统

CiteScore

9.10

自引率

10.00%

发文量

审稿时长

6-12 weeks

期刊介绍： Lung publishes original articles, reviews and editorials on all aspects of the healthy and diseased lungs, of the airways, and of breathing. Epidemiological, clinical, pathophysiological, biochemical, and pharmacological studies fall within the scope of the journal. Case reports, short communications and technical notes can be accepted if they are of particular interest.

期刊最新文献

Elevated Driving Pressure in Pressure-Controlled Ventilation: An Independent Risk Factor for Adverse Outcomes in Mechanically Ventilated Neonates. Long-Term Prognosis of Adult Patients with Persistent Cough Post COVID-19 and Its Risk Factors: A Nationwide Prospective Study. Energy and Protein Intake in Mild-Moderate COPD Patients. Lung Volumes in Tobacco-Exposed Individuals with Preserved Spirometry: An Overlooked Pointer of Respiratory Health? Mechanisms of Anti-Oxidants, N-Acetylcysteine and Elamipretide (SS-31), on Ozone-Induced Airway Hyperresponsiveness and Mucus Hypersecretion.